Exit Dishman Pharmaceuticals: Sharmila Joshi

Sharmila Joshi of sharmilajoshi.com told CNBC-TV18, "The trading has been suspended for Dishman Pharma and I was trying to see if you could get a date anywhere on any website but there does not seem to be any available date. In any case, it has not been traded for the last month, entire period of June it has not been traded and then we are talking of a possible sort of a thing in August."

"However, overall if you were to just look at the financials of Dishman standalone, then they are way above the rest of the pharmaceutical pack. So maybe some of this excitement was with the fact that this Swiss subsidiary is getting merged. I don’t really have a view on that, but post listing one should exit because it is trading above pharmaceutical valuations," she added.